
Opinion|Videos|September 13, 2024
Patient Experience With Intravenous and Subcutaneous Therapies
Author(s)Jennifer Seminerio, MD
An expert gastroenterologist dissects a study that analyzed patient experience with intravenous and subcutaneous biological therapies.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- A study has evaluated patient experience on IV vs. subQ therapies. What were the
results of the study, and do they influence your clinical practice?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves Lipfendra, first oral PCSK9 inhibitor
2
How the most favored nation drug pricing policy is quietly reshaping drug development and clinical research
3
Capital Rx is now Judi Rx in a company rebrand
4
FTC secures settlement with Caremark, locks in up to $8.5 billion in consumer savings
5

























